about
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to targ...
Read More
7.49
-0.15
(-1.96%)
3,227
XNAS Volume
XNAS 17 Mar, 2026 10:28 AM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Passage Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..